Pacira BioSciences PCRX
NASDAQ PCRX
$25.21 +0.20 (+0.80%)
At close: Oct 2, 2026 · 4:00 PM EDT

Pacira BioSciences (PCRX) Interest & Investment Income (2010 - 2026)

Updated

Pacira BioSciences' Interest & Investment Income was $1.94 million in Q2 2026, down 61.2% from $5.01 million a year earlier but up 0.7% from the prior quarter.

Analysis

Pacira BioSciences (PCRX) Interest & Investment Income (2010 - 2026) Analysis & Trends

On a trailing twelve-month basis, Pacira BioSciences' Interest & Investment Income was $14.7 million through Jun 30, 2026, down 35.9% year-over-year; for FY2025, it came in at $22.73 million, up 15.5% from FY2024.

  • Interest & Investment Income has now increased for four consecutive years, with a five-year compound annual growth rate of 37.5% (FY2020 to FY2025).
  • In earlier years, Interest & Investment Income was $19.69 million in FY2024 (+72.0%), $11.44 million in FY2023 (+152.0%), $4.54 million in FY2022 (+406.9%) and $896,000 in FY2021 (-80.6%).
  • Quarterly Interest & Investment Income has moved between $80,000 (Q4 2021) and $8.53 million (Q3 2025) over five years.
  • Compared with a year earlier, Interest & Investment Income has declined for three straight quarters, with growth averaging 13.3% over the last eight quarters.
  • The best year-over-year quarter for Interest & Investment Income over five years was Q2 2023 (growth of 737.7%); the worst was Q4 2021 (a decline of 88.5%).
  • Per Business Quant data, PCRX's Interest & Investment Income in the three quarters before Q2 2026 was $1.93 million (Q1 2026), $2.3 million (Q4 2025) and $8.53 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 219.00 Mn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 80.00 Mn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Pacira BioSciences 1.00 Bn 65.95 Mn 148.24 Mn 1.94 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.94 Mn
Mar 31, 2026 1.93 Mn
Dec 31, 2025 2.30 Mn
Sep 30, 2025 8.53 Mn
Jun 30, 2025 5.01 Mn
Mar 31, 2025 6.90 Mn
Dec 31, 2024 5.56 Mn
Sep 30, 2024 5.48 Mn
Jun 30, 2024 4.75 Mn
Mar 31, 2024 3.90 Mn
Dec 31, 2023 3.43 Mn
Sep 30, 2023 2.77 Mn
Jun 30, 2023 2.11 Mn
Mar 31, 2023 3.14 Mn
Dec 31, 2022 2.79 Mn
Sep 30, 2022 1.23 Mn
Jun 30, 2022 252,000.00
Mar 31, 2022 271,000.00
Dec 31, 2021 80,000.00
Sep 30, 2021 177,000.00
API Access

Pacira BioSciences Interest & Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=PCRX&period=max&api_key=YOUR_API_KEY